In the course of becoming a member of the “In Silico Human drug safety and efficacy” mailing list, you have provided information about yourself (‘personal data’), i.e. name and email address. We (the University of Oxford) are the ‘data controller’ for this information, which means we decide how to use it and are responsible for looking after it in accordance with the General Data Protection Regulation (GDPR) and associated data protection legislation.
We will use your data to send you information about our “In Silico Human drug safety and efficacy” project, and in details: i) periodic newsletter, including research outputs, activities, news, and upcoming events; ii) additional information/news relevant to the project.
We need to process your data for the above purposes, to meet our legitimate interests in creating a network across academia, industry, regulatory agencies and clinicians to accelerate the use of in silico methodologies for the evaluation of drug safety and efficacy.
You can unsubscribe at any time by following the Unsubscribe instructions at the bottom of any email received through this mailing list, i.e. by sending a blank email to insilicocardiotox-unsubscribe@maillist.ox.ac.uk.
We will only use your data for the purposes for which we collected it, unless we reasonably consider that we need to use it for another related reason and that reason is compatible with the original purpose. If we need to use your data for an unrelated purpose, we will seek your consent to use it for that new purpose.
We will not provide your data to other parts of the University of Oxford, or to other organisations so they can use it for marketing purposes.
Access to your data within the University will be provided to those who need to view it as part of their work in carrying out the purposes described above.
We will retain your data until you unsubscribe or ask us to change it or delete it.
We store and use your data on University premises in electronic form.
Your data will be held securely in accordance with the University’s policies and procedures. Further information is available on the University’s Information Security website.
Information on your rights in relation to your personal data are explained here.
If you wish to raise any queries or concerns about our use of your data, please contact us at insilicocardiotox@cs.oc.ac.uk.
This project "In Silico human-based methodologies for evaluation of drug safety and efficacy" has received funding from The National Centre for the Replacement, Refinement and Reduction of Animals in Research
Driven by 
Newt
Home | Site Map | Contact | Freedom of Information | Privacy Policy | Copyright | Accessibility | Oxford University
